Quick Answer
LakeShore Biopharma Co., Ltd. reported Earnings Per Share Diluted of $5.22 (loss) per share for the year ending 2025.
- LakeShore Biopharma Co., Ltd. showed an increase of +87.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from LakeShore Biopharma Co., Ltd.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), LakeShore Biopharma Co., Ltd.'s Earnings Per Share Diluted has declined by 68.4%.
- Historical annual values: Fiscal year 2025: $5.22 (loss) per share | Fiscal year 2024: $40.54 (loss) per share | Fiscal year 2023: $23.55 (loss) per share | Fiscal year 2022: $1.71 (loss) per share | Fiscal year 2021: $3.10 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: